These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 35845425)

  • 1. Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions.
    Sudarsanam H; Buhmann R; Henschler R
    Front Bioeng Biotechnol; 2022; 10():886637. PubMed ID: 35845425
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists.
    Petersen CT; Hassan M; Morris AB; Jeffery J; Lee K; Jagirdar N; Staton AD; Raikar SS; Spencer HT; Sulchek T; Flowers CR; Waller EK
    Blood Adv; 2018 Feb; 2(3):210-223. PubMed ID: 29386194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.
    Tam YK; Martinson JA; Doligosa K; Klingemann HG
    Cytotherapy; 2003; 5(3):259-72. PubMed ID: 12850795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution.
    Carlens S; Gilljam M; Remberger M; Aschan J; Christensson B; Dilber MS
    Exp Hematol; 2000 Oct; 28(10):1137-46. PubMed ID: 11027832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy.
    Urak R; Walter M; Lim L; Wong CW; Budde LE; Thomas S; Forman SJ; Wang X
    J Immunother Cancer; 2017; 5():26. PubMed ID: 28331616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Uncoupling of Canonical Phenotypic Markers and Functional Potency of
    Lieberman NAP; DeGolier K; Haberthur K; Chinn H; Moyes KW; Bouchlaka MN; Walker KL; Capitini CM; Crane CA
    Front Immunol; 2018; 9():150. PubMed ID: 29456538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes.
    Baldwin NG; Rice CD; Tuttle TM; Bear HD; Hirsch JI; Merchant RE
    J Neurooncol; 1997 Mar; 32(1):19-28. PubMed ID: 9049859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.
    Gargett T; Brown MP
    Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cells imprint adoptively transferred CD8
    Smith AS; Knochelmann HM; Wyatt MM; Rangel Rivera GO; Rivera-Reyes AM; Dwyer CJ; Ware MB; Cole AC; Neskey DM; Rubinstein MP; Liu B; Thaxton JE; Bartee E; Paulos CM
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells.
    Montcuquet N; Mercier-Letondal P; Perruche S; Duperrier A; Couturier M; Bouchekioua A; Bonyhadi M; Ferrand C; Tiberghien P; Robinet E
    Immunology; 2008 Nov; 125(3):320-30. PubMed ID: 18445006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Humanized Lym-1 CAR with Novel DAP10/DAP12 Signaling Domains Demonstrates Reduced Tonic Signaling and Increased Antitumor Activity in B-Cell Lymphoma Models.
    Zheng L; Ren L; Kouhi A; Khawli LA; Hu P; Kaslow HR; Epstein AL
    Clin Cancer Res; 2020 Jul; 26(14):3694-3706. PubMed ID: 32273277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes.
    Rice CD; Baldwin NG; Biron RT; Bear HD; Merchant RE
    J Neurooncol; 1997 Mar; 32(1):29-38. PubMed ID: 9049860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell receptor repertoires of ex vivo-expanded tumor-infiltrating lymphocytes from breast cancer patients.
    Park IA; Rajaei H; Kim YA; Lee H; Lee H; Seo JH; Heo SH; Song IH; Gong G; Lee HJ
    Immunol Res; 2020 Oct; 68(5):233-245. PubMed ID: 32886262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of the short-term ex vivo expansion on the adhesion characteristics and chemotactic function of expanded ex vivo CD34(+) cells].
    Zhai QL; Qiu LG; Li Q; Zhou Y; Yu Z; Meng HX; Han JL; Ying HG; Han ZC
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1262-5. PubMed ID: 12930644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically relevant T cell expansion media activate distinct metabolic programs uncoupled from cellular function.
    MacPherson S; Keyes S; Kilgour MK; Smazynski J; Chan V; Sudderth J; Turcotte T; Devlieger A; Yu J; Huggler KS; Cantor JR; DeBerardinis RJ; Siatskas C; Lum JJ
    Mol Ther Methods Clin Dev; 2022 Mar; 24():380-393. PubMed ID: 35284590
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes.
    Contassot E; Robinet E; Angonin R; Laithier V; Bittencourt M; Pavy JJ; Cahn JY; Hervé P; Tiberghien P
    Bone Marrow Transplant; 1998 Dec; 22(11):1097-102. PubMed ID: 9877273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model.
    Yang S; Archer GE; Flores CE; Mitchell DA; Sampson JH
    Cancer Immunol Immunother; 2013 Nov; 62(11):1649-62. PubMed ID: 23982483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.